UA102464U - PHARMACEUTICAL COMPOSITION - Google Patents
PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- UA102464U UA102464U UAU201505329U UAU201505329U UA102464U UA 102464 U UA102464 U UA 102464U UA U201505329 U UAU201505329 U UA U201505329U UA U201505329 U UAU201505329 U UA U201505329U UA 102464 U UA102464 U UA 102464U
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutically acceptable
- water
- salt
- acceptable salt
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Фармацевтична композиція на основі стабілізованого розчину двох активних речовин містить, як першу активну речовину, високомолекулярну гіалуронову кислоту та/або її фармацевтично прийнятну сіль, причому молекулярна маса такої кислоти або солі може бути від 401 кДа до 2,5 млн. Да, як другу активну речовину містить декаметоксин та/або його розчинну у воді сіль, стабілізатор, який є фармацевтично прийнятною сіллю, що здатна до розчинення у воді і дисоціації у водних розчинах на катіони металів та аніони кислотних залишків або сумішшю таких солей. При цьому стабілізатор має здатність утворювати одночасно з гіалуроновою кислотою та/або її фармацевтично прийнятною сіллю та з декаметоксином та/або його розчинною у воді сіллю, розчинні у воді сполуки, а також містить принаймні одну фармацевтично прийнятну добавку. A pharmaceutical composition based on a stable solution of two active substances contains, as the first active substance, high molecular weight hyaluronic acid and / or its pharmaceutically acceptable salt, the molecular weight of such acid or salt may be from 401 kDa to 2.5 million. the substance contains decamethoxine and / or its water-soluble salt, a stabilizer that is a pharmaceutically acceptable salt capable of dissolving in water and dissociating in aqueous solutions to metal cations and anions of acid residues or a mixture of such salts and. The stabilizer has the ability to form concurrently with hyaluronic acid and / or its pharmaceutically acceptable salt and with decamethoxin and / or its water-soluble salt, a water-soluble compound, and also contains at least one pharmaceutically acceptable additive.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201505329U UA102464U (en) | 2015-05-29 | 2015-05-29 | PHARMACEUTICAL COMPOSITION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201505329U UA102464U (en) | 2015-05-29 | 2015-05-29 | PHARMACEUTICAL COMPOSITION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA102464U true UA102464U (en) | 2015-10-26 |
Family
ID=54773948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201505329U UA102464U (en) | 2015-05-29 | 2015-05-29 | PHARMACEUTICAL COMPOSITION |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA102464U (en) |
-
2015
- 2015-05-29 UA UAU201505329U patent/UA102464U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000882A1 (en) | Compositions of arni against component c5 of the complement and methods for its use (divisional sol. No. 2710-15). | |
| EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
| EA201792354A1 (en) | BATCHOLEIC ACID COMPOSITIONS AND METHODS OF APPLICATION | |
| EA201692301A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
| CR20160499A (en) | STABLE COMPOSITIONS OF IODINE NOT IN COMPLEX AND METHODS OF USE | |
| MX2016002368A (en) | Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators. | |
| EA201691825A1 (en) | STABILIZED SOLUTION ON THE BASIS OF ACTIVE SUBSTANCES, METHOD FOR OBTAINING A STABILIZED SOLUTION OF ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION ON THE BASIS OF A STABILIZED SOLUTION OF ACTIVE SUBSTANCES (TWO OPTIONS) | |
| MX2019012285A (en) | Methods of treating developmental encephalopathies. | |
| RU2019139886A (en) | THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS | |
| MY169131A (en) | Aqueous solutions containing a complexing agent in high concentration | |
| MX2017006900A (en) | Aqueous solution containing combination of complexing agents. | |
| PH12016500738A1 (en) | Formulation for gonadotropins | |
| IN2013MU03773A (en) | ||
| EA201791191A1 (en) | WATER PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION IN THE ORAL CAVITY CONTAINING FLURBIPROPHENE AND DEXPANTENOL | |
| EA202091561A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE LENALIDOMIDE SALT | |
| UA102464U (en) | PHARMACEUTICAL COMPOSITION | |
| PH12015502717A1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| NZ603783A (en) | Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant | |
| UA102461U (en) | PHARMACEUTICAL COMPOSITION | |
| UA116892C2 (en) | PHARMACEUTICAL COMPOSITION | |
| MY186384A (en) | Mixed salts of hydroxyalkane sulfinic acid | |
| UA102463U (en) | STABILIZED SOLUTION | |
| EA201692196A1 (en) | APPLICATION OF 1,3-PROPANDISULPHONE ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OF SARKOIDOS | |
| UA102462U (en) | METHOD OF OBTAINING A STABILIZED SOLUTION | |
| CO2016004668A2 (en) | Composition based on a stabilized solution of active ingredients |